enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Patients push back against Novo Nordisk move to scrap an ...

    www.aol.com/news/patients-push-back-against-novo...

    Novo Nordisk's decision to stop selling its long-acting insulin Levemir in the United States has left some diabetes patients struggling to switch treatments, patients and doctors in a dozen U.S ...

  3. Novo Nordisk to discontinue Levemir insulin in U.S. market - AOL

    www.aol.com/news/novo-nordisk-discontinue...

    Basal insulin such as Levemir is a type of long-acting insulin injected once or twice a day as opposed to rapid, short, or intermediate-acting insulin. It is often used by people with Type 1 ...

  4. Senate panel questions Novo Nordisk CEO over decision to ...

    www.aol.com/senate-panel-questions-novo-nordisk...

    Sen, Maggie Hassan, D- New Hampshire, said Levemir is a critical insulin and questioned the company's decision to halt sales. In doing so, Novo Nordisk "interrupted the diabetes care plans of ...

  5. Insulin detemir - Wikipedia

    en.wikipedia.org/wiki/Insulin_detemir

    Insulin detemir, sold under the brand name Levemir among others, is a long-acting modified form of medical insulin used to treat both type 1 and type 2 diabetes. [6] It is used by injection under the skin . [ 6 ]

  6. Insulin analog - Wikipedia

    en.wikipedia.org/wiki/Insulin_analog

    Novo Nordisk created insulin detemir and markets it under the trade name Levemir as a long-lasting insulin analogue for maintaining the basal level of insulin. [1] [5] The basal level of insulin may be maintained for up to 20 hours, but the time is affected by the size of the injected dose.

  7. Insulin degludec - Wikipedia

    en.wikipedia.org/wiki/Insulin_degludec

    Insulin degludec is a modified insulin that has one single amino acid deleted in comparison to human insulin, and is conjugated to hexadecanedioic acid via gamma-L-glutamyl spacer at the amino acid lysine at position B29. It is included on the World Health Organization's List of Essential Medicines [11] as an equivalent to insulin glargine.

  8. Patients Are Suing Over Alleged Side Effects of Weight ... - AOL

    www.aol.com/patients-suing-over-alleged-side...

    While most patients take GLP-1 drugs with few or no serious side effects, it's common to experience at least mild gastrointestinal issues like nausea, vomiting, stomach pain, constipation, and ...

  9. Latent autoimmune diabetes in adults - Wikipedia

    en.wikipedia.org/wiki/Latent_autoimmune_diabetes...

    A fasting blood sugar level of ≥ 7.0 mmol / L (126 mg/dL) is used in the general diagnosis of diabetes. [17] There are no clear guidelines for the diagnosis of LADA, but the criteria often used are that the patient should develop the disease in adulthood, not need insulin treatment for the first 6 months after diagnosis and have autoantibodies in the blood.